Bath Savings Trust Co Raises Stake in Colgate-Palmolive (NYSE:CL)

Bath Savings Trust Co lifted its stake in shares of Colgate-Palmolive (NYSE:CL) by 2.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 58,137 shares of the company’s stock after acquiring an additional 1,655 shares during the period. Bath Savings Trust Co’s holdings in Colgate-Palmolive were worth $5,285,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Reston Wealth Management LLC acquired a new position in Colgate-Palmolive in the 3rd quarter valued at about $42,000. Capital Performance Advisors LLP acquired a new position in Colgate-Palmolive in the third quarter valued at approximately $53,000. Prospera Private Wealth LLC purchased a new position in Colgate-Palmolive in the third quarter worth approximately $64,000. True Wealth Design LLC increased its stake in Colgate-Palmolive by 1,460.9% during the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after acquiring an additional 672 shares during the last quarter. Finally, Continuum Advisory LLC raised its position in Colgate-Palmolive by 93.4% in the third quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock valued at $79,000 after purchasing an additional 368 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.2 %

Shares of CL traded up $0.21 during mid-day trading on Tuesday, reaching $87.75. The company’s stock had a trading volume of 1,893,685 shares, compared to its average volume of 3,555,586. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a 12-month low of $79.69 and a 12-month high of $109.30. The stock has a market cap of $71.69 billion, a PE ratio of 25.14, a price-to-earnings-growth ratio of 3.31 and a beta of 0.44. The company’s 50 day moving average is $93.18 and its 200 day moving average is $98.38.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.28%. Colgate-Palmolive’s payout ratio is currently 57.31%.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on CL shares. TD Cowen cut their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and boosted their price target for the company from $107.00 to $109.00 in a research note on Monday, September 9th. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Wednesday, January 1st. Stifel Nicolaus lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their target price for the company from $105.00 to $101.00 in a research report on Monday, October 28th. Finally, Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus price target of $104.16.

Insider Activity

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.